UPDATE 1-Ardelyx kidney drug meets main goal in mid-stage study
February 02, 2015 at 08:40 AM EST
Feb 2 (Reuters) - Ardelyx Inc said its experimental drug "significantly" decreased phosphate levels in chronic kidney disease patients who were on dialysis.
